Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central nervous system mesenchymal chondrosarcoma.

M Salvati1, E Caroli, A Frati

  • 1Dept. of Neurosurgery, Policlinico S. Andrea, La Sapienza University, Rome, Italy. salvati.maurizio@libero.it

Journal of Experimental & Clinical Cancer Research : CR
|August 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isorhythmic atrioventricular dissociation in an alert normothermic cat.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2026
Same author

Perioperative Predictors of Recurrency in Chronic Subdural Hematoma: A Retrospective Analysis of 150 Consecutive Cases.

World neurosurgery·2025
Same author

Unraveling the complexity of anti-doping analysis: reassessing meldonium detection and doping verdicts in a case study.

European review for medical and pharmacological sciences·2023
Same author

Salivary gland tissues and derived primary and metastatic neoplasms: unusual pitfalls in the work-up of sellar lesions. A systematic review.

Journal of endocrinological investigation·2021
Same author

Typical CT findings of COVID-19 pneumonia in patients presenting with repetitive negative RT-PCR.

Radiography (London, England : 1995)·2020
Same author

Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14.

Neuropathology and applied neurobiology·2019
Same journal

Extracellular vesicle-mediated GALNT1/RPRD1A glycosylation axis drives immune escape and peritoneal metastasis in gastric cancer.

Journal of experimental & clinical cancer research : CR·2026
Same journal

NHE7-Driven endoplasmic reticulum stress signaling transmission promotes malignant progression of endometrial cancer via c-Fos/PRSS1/ERP27 axis.

Journal of experimental & clinical cancer research : CR·2026
Same journal

Correction: Nanovaccines with ferroptosis, necroptosis and STING-activation for synergistic immunotherapy.

Journal of experimental & clinical cancer research : CR·2026
Same journal

Adipocyte-rich microenvironment promotes TNBC progression through SIRT6-associated ACSL5 dysregulation and lipid storage-associated phenotypes.

Journal of experimental & clinical cancer research : CR·2026
Same journal

Correction: Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling.

Journal of experimental & clinical cancer research : CR·2026
Same journal

Decoding glioblastoma evolution and heterogeneity through mechanistic modeling: implications for clinical translation.

Journal of experimental & clinical cancer research : CR·2026
See all related articles

Central nervous system mesenchymal chondrosarcomas are rare tumors. Radical surgical removal offers the best prognosis, with postoperative radiotherapy potentially improving survival rates for these challenging brain tumors.

Area of Science:

  • Neuro-oncology
  • Surgical Pathology

Background:

  • Central nervous system (CNS) mesenchymal chondrosarcomas are rare, distinct malignant tumors.
  • The clinical behavior and prognosis of these intracranial tumors remain poorly understood.

Observation:

  • This study presents two cases of intracranial mesenchymal chondrosarcoma.
  • A comprehensive literature review of 55 reported cases was conducted.

Findings:

  • Radical surgical removal is identified as the optimal therapeutic strategy.
  • While not statistically significant, patients receiving postoperative radiotherapy showed a trend toward improved survival.
  • Adjuvant chemotherapy did not appear to influence survival times.

Implications:

Related Experiment Videos

  • Further research is needed to define the clinical characteristics and optimal treatment for CNS mesenchymal chondrosarcomas.
  • Postoperative radiotherapy may be a beneficial adjunct to surgical resection.
  • Early diagnosis and aggressive surgical management are crucial for improving patient outcomes.